U.S. markets closed
  • S&P 500

    3,913.10
    -2.36 (-0.06%)
     
  • Dow 30

    32,627.97
    -234.33 (-0.71%)
     
  • Nasdaq

    13,215.24
    +99.07 (+0.76%)
     
  • Russell 2000

    2,287.55
    +19.96 (+0.88%)
     
  • Crude Oil

    61.44
    +1.44 (+2.40%)
     
  • Gold

    1,743.90
    +11.40 (+0.66%)
     
  • Silver

    26.33
    -0.02 (-0.06%)
     
  • EUR/USD

    1.1908
    -0.0011 (-0.10%)
     
  • 10-Yr Bond

    1.7320
    +0.0020 (+0.12%)
     
  • GBP/USD

    1.3870
    -0.0060 (-0.43%)
     
  • USD/JPY

    108.9010
    -0.0360 (-0.03%)
     
  • BTC-USD

    59,499.23
    +591.19 (+1.00%)
     
  • CMC Crypto 200

    1,172.11
    +20.53 (+1.78%)
     
  • FTSE 100

    6,708.71
    -70.97 (-1.05%)
     
  • Nikkei 225

    29,792.05
    -424.70 (-1.41%)
     

BREAKING NEWS ALERT: Halper Sadeh LLP Continues to Investigate PRAH, RMBL, GNMK, FLIR; Shareholders Are Encouraged to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / March 20, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

PRA Health Sciences, Inc. (NASDAQ:PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to ICON plc. Under the terms of the transaction, PRA Health shareholders will receive $80.00 in cash and 0.4125 shares of ICON stock for each PRA Health share that they own. If you are a PRA Health shareholder, click here to learn more about your rights and options.

RumbleOn, Inc. (NASDAQ:RMBL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with RideNow. If you are a RumbleOn shareholder, click here to learn more about your rights and options.

GenMark Diagnostics, Inc. (NASDAQ:GNMK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Roche for $24.05 per share in cash. If you are a GenMark shareholder, click here to learn more about your rights and options.

FLIR Systems, Inc. (NASDAQ:FLIR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Teledyne Technologies Incorporated for $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share. If you are a FLIR shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/636659/BREAKING-NEWS-ALERT-Halper-Sadeh-LLP-Continues-to-Investigate-PRAH-RMBL-GNMK-FLIR-Shareholders-Are-Encouraged-to-Contact-the-Firm